Clinical Trials Browser

Withdrawn × Esophageal Neoplasms × Paclitaxel × Clear all

NCT05245760 2022-11-08

CRATER

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms

NCT02274012 2017-03-14

Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment

Phase 2 Withdrawn

Gastrointestinal

Esophageal Neoplasms, Neoplasm Metastasis

NCT02598687 2016-04-21

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Phase 1 Withdrawn

Gastrointestinal

Esophageal Neoplasms